世界の脳梗塞治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Cerebral Infarction Therapy Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5429 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3日） • 産業分類：新技術

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、脳梗塞治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（部分的前循環梗塞（PACI）、全前循環梗塞（TACI）、後部循環梗塞（POCI））、用途別市場規模（病院、診療所、医学研究機関）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・脳梗塞治療の市場動向 ・企業の競争状況、市場シェア ・脳梗塞治療の種類別市場規模と予測2016-2027（部分的前循環梗塞（PACI）、全前循環梗塞（TACI）、後部循環梗塞（POCI）） ・脳梗塞治療の用途別市場規模と予測2016-2027（病院、診療所、医学研究機関） ・脳梗塞治療の北米市場規模2016-2027（アメリカ、カナダ） ・脳梗塞治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・脳梗塞治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・脳梗塞治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・脳梗塞治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Daiichi Sankyo、Johnson＆Johnson、Aprogen、Baxter、Otsuka、Mitsubishi Chemical Holdings Corporation、Nordmark、Takeda、Sanofi、Bristol-Myers Squibb、Kanion Pharmaceutical） ・結論

Cerebral infarction is a chronic and life-threatening disease.Cerebral infarction is one of the most important types of ischemic stroke in which blood enters the brain due to the development of blockages or clots in blood vessels.It is important to emphasize that cerebral infarction is different from cerebral hemorrhage.The chance of death is high because of the sudden onset of the disease.

In 2021, the global Cerebral Infarction Therapy market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027.
This report focuses on the global Cerebral Infarction Therapy status, future forecast, growth opportunity, key market, and key players. The study objectives are to present the Cerebral Infarction Therapy development in North America, Europe, Japan, China, Southeast Asia, India, etc.

Global Cerebral Infarction Therapy Scope and Market Size
Cerebral Infarction Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cerebral Infarction Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Partial Anterior Circulation Infarct (PACI)
Total Anterior Circulation Infarct (TACI)
Posterior Circulation Infarct (POCI)

Segment by Application
Hospital
Clinic
Medical Research Organization

By Region
North America
Europe
Japan
China
Southeast Asia
India

By Company
Daiichi Sankyo
Johnson＆Johnson
Aprogen
Baxter
Otsuka
Mitsubishi Chemical Holdings Corporation
Nordmark
Takeda
Sanofi
Bristol-Myers Squibb
Kanion Pharmaceutical

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cerebral Infarction Therapy Market Size Growth Rate by Type (2021-2027)
1.2.2 Partial Anterior Circulation Infarct (PACI)
1.2.3 Total Anterior Circulation Infarct (TACI)
1.2.4 Posterior Circulation Infarct (POCI)
1.3 Market by Application
1.3.1 Global Cerebral Infarction Therapy Market Share by Application (2021-2027)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Medical Research Organization
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Cerebral Infarction Therapy Market Size
2.2 Cerebral Infarction Therapy Market Size by Regions
2.2.1 Cerebral Infarction Therapy Growth Rate by Regions (2021-2027)
2.2.2 Cerebral Infarction Therapy Market Share by Regions (2021-2027)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases

3 Key Players
3.1 Cerebral Infarction Therapy Revenue by Players (2020-2021)
3.2 Cerebral Infarction Therapy Key Players Headquaters and Area Served
3.3 Key Players Cerebral Infarction Therapy Product/Solution/Service
3.4 Date of Enter into Cerebral Infarction Therapy Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown by Type and by Application
4.1 Global Cerebral Infarction Therapy Market Size by Type (2021-2027)
4.2 Global Cerebral Infarction Therapy Market Size by Application (2021-2027)

5 North America
5.1 North America Cerebral Infarction Therapy Market Forecast (2021-2027)
5.2 Cerebral Infarction Therapy Key Players in North America
5.3 North America Cerebral Infarction Therapy Market Size by Type
5.4 North America Cerebral Infarction Therapy Market Size by Application
6.4.4 Canada

6 Europe
6.1 Europe Cerebral Infarction Therapy Market Forecast (2021-2027)
6.2 Cerebral Infarction Therapy Key Players in Europe
6.3 Europe Cerebral Infarction Therapy Market Size by Type
6.4 Europe Cerebral Infarction Therapy Market Size by Application

7 Japan
7.1 Japan Cerebral Infarction Therapy Market Forecast (2021-2027)
7.2 Cerebral Infarction Therapy Key Players in Europe
7.3 Japan Cerebral Infarction Therapy Market Size by Type
7.4 Japan Cerebral Infarction Therapy Market Size by Application

8 Rest of World
8.1 China
8.1.1 China Cerebral Infarction Therapy Market Analysis
8.1.2 Key Players in China
8.2 Southeast Asia
8.2.1 Southeast Asia Cerebral Infarction Therapy Market Analysis
8.2.2 Key Players in Southeast Asia
8.3 India
8.3.1 India Cerebral Infarction Therapy Market Analysis
8.3.2 Key Players in India

9 International Player Profiles
9.1 Daiichi Sankyo
9.1.1 Daiichi Sankyo Company Details
9.1.2 Daiichi Sankyo Description and Business Overview
9.1.3 Daiichi Sankyo Cerebral Infarction Therapy Introduction
9.1.4 Daiichi Sankyo Revenue in Cerebral Infarction Therapy Business (2020-2021)
9.1.5 Daiichi Sankyo Recent Development
9.2 Johnson＆Johnson
9.2.1 Johnson＆Johnson Company Details
9.2.2 Johnson＆Johnson Description and Business Overview
9.2.3 Johnson＆Johnson Cerebral Infarction Therapy Introduction
9.2.4 Johnson＆Johnson Revenue in Cerebral Infarction Therapy Business (2020-2021)
9.2.5 Johnson＆Johnson Recent Development
9.3 Aprogen
9.3.1 Aprogen Company Details
9.3.2 Aprogen Description and Business Overview
9.3.3 Aprogen Cerebral Infarction Therapy Introduction
9.3.4 Aprogen Revenue in Cerebral Infarction Therapy Business (2020-2021)
9.3.5 Aprogen Recent Development
9.4 Baxter
9.4.1 Baxter Company Details
9.4.2 Baxter Description and Business Overview
9.4.3 Baxter Cerebral Infarction Therapy Introduction
9.4.4 Baxter Revenue in Cerebral Infarction Therapy Business (2020-2021)
9.4.5 Baxter Recent Development
9.5 Otsuka
9.5.1 Otsuka Company Details
9.5.2 Otsuka Description and Business Overview
9.5.3 Otsuka Cerebral Infarction Therapy Introduction
9.5.4 Otsuka Revenue in Cerebral Infarction Therapy Business (2020-2021)
9.5.5 Otsuka Recent Development
9.6 Mitsubishi Chemical Holdings Corporation
9.6.1 Mitsubishi Chemical Holdings Corporation Company Details
9.6.2 Mitsubishi Chemical Holdings Corporation Description and Business Overview
9.6.3 Mitsubishi Chemical Holdings Corporation Cerebral Infarction Therapy Introduction
9.6.4 Mitsubishi Chemical Holdings Corporation Revenue in Cerebral Infarction Therapy Business (2020-2021)
9.6.5 Mitsubishi Chemical Holdings Corporation Recent Development
9.7 Nordmark
9.7.1 Nordmark Company Details
9.7.2 Nordmark Description and Business Overview
9.7.3 Nordmark Cerebral Infarction Therapy Introduction
9.7.4 Nordmark Revenue in Cerebral Infarction Therapy Business (2020-2021)
9.7.5 Nordmark Recent Development
9.8 Takeda
9.8.1 Takeda Company Details
9.8.2 Takeda Description and Business Overview
9.8.3 Takeda Cerebral Infarction Therapy Introduction
9.8.4 Takeda Revenue in Cerebral Infarction Therapy Business (2020-2021)
9.8.5 Takeda Recent Development
9.9 Sanofi
9.9.1 Sanofi Company Details
9.9.2 Sanofi Description and Business Overview
9.9.3 Sanofi Cerebral Infarction Therapy Introduction
9.9.4 Sanofi Revenue in Cerebral Infarction Therapy Business (2020-2021)
9.9.5 Sanofi Recent Development
9.10 Bristol-Myers Squibb
9.10.1 Bristol-Myers Squibb Company Details
9.10.2 Bristol-Myers Squibb Description and Business Overview
9.10.3 Bristol-Myers Squibb Cerebral Infarction Therapy Introduction
9.10.4 Bristol-Myers Squibb Revenue in Cerebral Infarction Therapy Business (2020-2021)
9.10.5 Bristol-Myers Squibb Recent Development
9.11 Kanion Pharmaceutical
9.11.1 Kanion Pharmaceutical Company Details
9.11.2 Kanion Pharmaceutical Description and Business Overview
9.11.3 Kanion Pharmaceutical Cerebral Infarction Therapy Introduction
9.11.4 Kanion Pharmaceutical Revenue in Cerebral Infarction Therapy Business (2020-2021)
9.11.5 Kanion Pharmaceutical Recent Development

10 Market Dynamics
10.1 Industry Trends
10.2 Market Drives
10.3 Market Challenges
10.4 Market Restraints

11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Tables
Table 1. Global Cerebral Infarction Therapy Market Size Growth Rate by Type (2021-2027) (US$ Million)
Table 2. Key Players of Partial Anterior Circulation Infarct (PACI)
Table 3. Key Players of Total Anterior Circulation Infarct (TACI)
Table 4. Key Players of Posterior Circulation Infarct (POCI)
Table 5. Global Cerebral Infarction Therapy Market Size Growth by Application (2021-2027) (US$ Million)
Table 6. Global Cerebral Infarction Therapy Market Size by Regions (2021-2027) (US$ Million)
Table 7. Global Cerebral Infarction Therapy Market Share by Regions (2021-2027)
Table 8. Market Top Trends
Table 9. Market Use Cases
Table 10. Global Cerebral Infarction Therapy Revenue by Players (2020-2021) (US$ Million)
Table 11. Global Cerebral Infarction Therapy Market Share by Players (2020-2021)
Table 12. Key Players Headquarters and Area Served
Table 13. Key Players Cerebral Infarction Therapy Product Solution and Service
Table 14. Date of Enter into Cerebral Infarction Therapy Market
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Cerebral Infarction Therapy Market Size by Type (2021-2027) (US$ Million)
Table 17. Global Cerebral Infarction Therapy Market Size Share by Type (2021-2027)
Table 18. Global Cerebral Infarction Therapy Market Size by Application (2021-2027) (US$ Million)
Table 19. Global Cerebral Infarction Therapy Market Size Share by Application (2021-2027)
Table 20. North America Key Players Cerebral Infarction Therapy Revenue (2020-2021) (US$ Million)
Table 21. North America Key Players Cerebral Infarction Therapy Market Share (2020-2021)
Table 22. North America Cerebral Infarction Therapy Market Size by Type (2021-2027) (US$ Million)
Table 23. North America Cerebral Infarction Therapy Market Share by Type (2021-2027)
Table 24. North America Cerebral Infarction Therapy Market Size by Application (2021-2027) (US$ Million)
Table 25. North America Cerebral Infarction Therapy Market Share by Application (2021-2027)
Table 26. Europe Key Players Cerebral Infarction Therapy Revenue (2020-2021) (US$ Million)
Table 27. Europe Key Players Cerebral Infarction Therapy Market Share (2020-2021)
Table 28. Europe Cerebral Infarction Therapy Market Size by Type (2021-2027) (US$ Million)
Table 29. Europe Cerebral Infarction Therapy Market Share by Type (2021-2027)
Table 30. Europe Cerebral Infarction Therapy Market Size by Application (2021-2027) (US$ Million)
Table 31. Europe Cerebral Infarction Therapy Market Share by Application (2021-2027)
Table 32. Japan Key Players Cerebral Infarction Therapy Revenue (2020-2021) (US$ Million)
Table 33. Japan Key Players Cerebral Infarction Therapy Market Share (2020-2021)
Table 34. Japan Cerebral Infarction Therapy Market Size by Type (2021-2027) (US$ Million)
Table 35. Japan Cerebral Infarction Therapy Market Share by Type (2021-2027)
Table 36. Japan Cerebral Infarction Therapy Market Size by Application (2021-2027) (US$ Million)
Table 37. Japan Cerebral Infarction Therapy Market Share by Application (2021-2027)
Table 38. Key Players in China
Table 39. Key Players in Southeast Asia
Table 40. Key Players in India
Table 41. Daiichi Sankyo Company Details
Table 42. Daiichi Sankyo Description and Business Overview
Table 43. Daiichi Sankyo Cerebral Infarction Therapy Product
Table 44. Daiichi Sankyo Revenue in Cerebral Infarction Therapy Business 2020 and 2021
Table 45. Daiichi Sankyo Recent Development
Table 46. Johnson＆Johnson Company Details
Table 47. Johnson＆Johnson Description and Business Overview
Table 48. Johnson＆Johnson Cerebral Infarction Therapy Product
Table 49. Johnson＆Johnson Revenue in Cerebral Infarction Therapy Business 2020 and 2021
Table 50. Johnson＆Johnson Recent Development
Table 51. Aprogen Company Details
Table 52. Aprogen Description and Business Overview
Table 53. Aprogen Cerebral Infarction Therapy Product
Table 54. Aprogen Revenue in Cerebral Infarction Therapy Business 2020 and 2021
Table 55. Aprogen Recent Development
Table 56. Baxter Company Details
Table 57. Baxter Description and Business Overview
Table 58. Baxter Cerebral Infarction Therapy Product
Table 59. Baxter Revenue in Cerebral Infarction Therapy Business 2020 and 2021
Table 60. Baxter Recent Development
Table 61. Otsuka Company Details
Table 62. Otsuka Description and Business Overview
Table 63. Otsuka Cerebral Infarction Therapy Product
Table 64. Otsuka Revenue in Cerebral Infarction Therapy Business 2020 and 2021
Table 65. Otsuka Recent Development
Table 66. Mitsubishi Chemical Holdings Corporation Company Details
Table 67. Mitsubishi Chemical Holdings Corporation Description and Business Overview
Table 68. Mitsubishi Chemical Holdings Corporation Cerebral Infarction Therapy Product
Table 69. Mitsubishi Chemical Holdings Corporation Revenue in Cerebral Infarction Therapy Business 2020 and 2021
Table 70. Mitsubishi Chemical Holdings Corporation Recent Development
Table 71. Nordmark Company Details
Table 72. Nordmark Description and Business Overview
Table 73. Nordmark Cerebral Infarction Therapy Product
Table 74. Nordmark Revenue in Cerebral Infarction Therapy Business 2020 and 2021
Table 75. Nordmark Recent Development
Table 76. Takeda Company Details
Table 77. Takeda Description and Business Overview
Table 78. Takeda Cerebral Infarction Therapy Product
Table 79. Takeda Revenue in Cerebral Infarction Therapy Business 2020 and 2021
Table 80. Takeda Recent Development
Table 81. Sanofi Company Details
Table 82. Sanofi Description and Business Overview
Table 83. Sanofi Cerebral Infarction Therapy Product
Table 84. Sanofi Revenue in Cerebral Infarction Therapy Business 2020 and 2021
Table 85. Sanofi Recent Development
Table 86. Bristol-Myers Squibb Company Details
Table 87. Bristol-Myers Squibb Description and Business Overview
Table 88. Bristol-Myers Squibb Cerebral Infarction Therapy Product
Table 89. Bristol-Myers Squibb Revenue in Cerebral Infarction Therapy Business 2020 and 2021
Table 90. Bristol-Myers Squibb Recent Development
Table 91. Kanion Pharmaceutical Company Details
Table 92. Kanion Pharmaceutical Description and Business Overview
Table 93. Kanion Pharmaceutical Cerebral Infarction Therapy Product
Table 94. Kanion Pharmaceutical Revenue in Cerebral Infarction Therapy Business 2020 and 2021
Table 95. Kanion Pharmaceutical Recent Development
Table 96. Cerebral Infarction Therapy Market Trends
Table 97. Cerebral Infarction Therapy Market Drivers
Table 98. Cerebral Infarction Therapy Market Challenges
Table 99. Cerebral Infarction Therapy Market Restraints
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cerebral Infarction Therapy Market Share by Type in 2021 & 2027
Figure 2. Partial Anterior Circulation Infarct (PACI) Features
Figure 3. Total Anterior Circulation Infarct (TACI) Features
Figure 4. Posterior Circulation Infarct (POCI) Features
Figure 5. Global Cerebral Infarction Therapy Market Share by Application in 2021 & 2027
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Medical Research Organization Case Studies
Figure 9. Cerebral Infarction Therapy Report Years Considered
Figure 10. Global Cerebral Infarction Therapy Market Size and Growth Rate (2020-2027) (US$ Million)
Figure 11. Global Cerebral Infarction Therapy Market Share by Regions (2020-2027)
Figure 12. Global Cerebral Infarction Therapy Market Share by Players in 2021
Figure 13. Global Cerebral Infarction Therapy Market Size Market Share by Type (2021-2027)
Figure 14. Global Cerebral Infarction Therapy Market Size Market Share by Application (2021-2027)
Figure 15. Global Cerebral Infarction Therapy Revenue Market Share by Application in 2021
Figure 16. North America Cerebral Infarction Therapy Market Size 2021-2027 (US$ Million)
Figure 17. Europe Cerebral Infarction Therapy Market Size 2021-2027 (US$ Million)
Figure 18. Japan Cerebral Infarction Therapy Market Size 2021-2027 (US$ Million)
Figure 19. Cerebral Infarction Therapy Market Size in China (2021-2027) (US$ Million)
Figure 20. Cerebral Infarction Therapy Market Size in Southeast Asia (2021-2027) (US$ Million)
Figure 21. Cerebral Infarction Therapy Market Size in India (2021-2027) (US$ Million)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed

---